@samtalks_peps

1 post audited · 6 claims analysed

Instagram profile

Science evidence grade

33%Low evidence grade

Based on 6 claims across 1 audit

SupportedOverstatedMisleadingNo Evidence

2

Supported

33%

0

Overstated

0%

0

Misleading

0%

4

No Evidence

67%

Share this evidence grade

Claim-level evidence grades — not a character judgment. Methodology · Right of reply · Leaderboards

What @samtalks_peps claims actually are

We separate claims into three buckets: backed by evidence, factually incorrect, and grey — like animal-only findings sold as human fact (e.g. BPC-157 “fixes Achilles” from rat studies).

Evidence-based

33%

2 claims

Claims that align with published human or clinical evidence at the stated strength.

Ex: “Semaglutide can reduce body weight in adults with obesity” — supported by large RCTs.

Factually incorrect

0%

0 claims

Claims that conflict with the evidence, invent certainty, or omit critical safety/context in a misleading way.

Ex: “Peptides have no side effects” — contradicts known adverse-event profiles.

Grey / overstated

67%

4 claims

Plausible direction but wrong certainty — animal-only data sold as human fact, dose/effect overstated, or no adequate published support yet.

Ex: “BPC-157 fixes Achilles tears” — often rests on rodent tendon models, not proven human Achilles repair trials.

Evidence mix

Share of audited claims in each bucket

Loading…
BackedIncorrectGrey

Verdict detail

Grey splits into overstated (wrong certainty) vs no published support

Loading…

Claims over time

Stacked by bucket as audits land — plus the running evidence grade

Loading…

Gold line = running science evidence grade (Supported + ½ Overstated ÷ total claims).

Audit history(1 post)

Post thumbnail
Supported
Audited Jul 30, 2026·about 20 hours ago·View source

The answer might surprise you…

Five of six claims (Claims 1–4, 6) have no detectable scientific support in PubMed, clinical trial registries, or peer-reviewed literature. Claim 5 (MOTS-c and mitochondrial stress) shows genuine early clinical interest, with an active human trial measuring MOTS-c during oxidative stress conditions and internal reference to preclinical cardiac stress models; however, this represents exploratory research rather than established efficacy. Across all claims, no specific studies are cited by the creator, and no human clinical evidence demonstrates any of these proposed benefits for a product called 'motsy' or 'MOTS-c.'

Audit another post from @samtalks_peps

Paste their social post link to add a new audit

New audit